三月 2026
- Home
- Catalent
三月 2026的Catalent市场份额分析
Catalent, Inc. is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. It employs more than 14,000 people, including approximately 2,400 scientists and technicians.
Catalent(包含公司地区分支机构)
查看更多网站流量和参与度信息- catalent.com
Catalent收入截至 三月 2026为 > 1B
Catalent主要域名产生的收入
3 年中Catalent主要域名的收入
Catalent主要域名的收入
Catalent热门域名的总访问量
了解Catalent市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Catalent热门域名的平均访问时长
分析Catalent参与度指标。
过去 3 个月的平均访问时长
子公司明细
Catalent热门域名的平均页面浏览量
了解Catalent如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Catalent 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻George Fotiades leaves Catalent Pharma Solutions.Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair.
四月 28, 2026阅读更多
新闻Cartherics Pty ltd partnered with Catalent Pharma Solutions on Apr 10th '26.Melbourne, Australia, and Tampa, FL - Cartherics Pty Ltd, a biotechnology company developing off-the-shelf immune cell therapies for high-impact women's diseases, including ovarian cancer and endometriosis, and Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, today announced an enhanced partnership.
四月 10, 2026阅读更多
新闻Proveca Ltd partners with Catalent Pharma Solutions."Proveca are delighted to announce this exclusive agreement with Catalent for its Zydis(R) ODT technology to support the expansion of our glycopyrrolate product offering (building on our Sialanar(R) oral liquid) across Europe, USA and other Worldwide markets.
二月 11, 2026阅读更多
查看 Catalent 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
